Does HRT prevent dementia? What the trials and big studies show

Brain fog is one of the most frustrating parts of menopause. Words go missing, you walk into a room and forget why, and it is natural to wonder whether replacing estrogen could protect your memory for the long run. It is an appealing idea. Here is what the research has actually found so far.

The short answer

Hormone therapy has not been shown to prevent dementia. The Menopause Society says that, in the absence of more definitive findings, hormone therapy is not recommended at any age to prevent or treat a decline in cognitive function or dementia ^[1]. FDA labeling for an approved estradiol and progesterone capsule says its safety and effectiveness for preventing dementia have not been established ^[10].

That is a separate question from whether hormones help menopause symptoms. Hormone therapy remains the most effective treatment for hot flashes and night sweats ^[1]. It is the long-term brain-protection claim that the evidence does not support.

What the WHI Memory Study found in women 65 and older

The Women's Health Initiative Memory Study (WHIMS) enrolled women aged 65 and older from the WHI hormone trials who did not have dementia when they started ^{[2, 3]}.

Estrogen plus progestin

In this arm, 4,532 women took either a daily combination pill or a placebo ^[2]. Over about 4 years, 40 women on hormones and 21 on placebo were diagnosed with probable dementia, a rate of 45 versus 22 per 10,000 women per year ^[2]. That works out to about 23 extra cases per 10,000 women per year ^[2]. Alzheimer disease was the most common type diagnosed in both groups, and the combination did not prevent mild cognitive impairment either ^[2].

Estrogen alone

In the estrogen-alone arm, 2,947 women who had had a hysterectomy took estrogen or placebo ^[3]. Twenty-eight women on estrogen and 19 on placebo developed probable dementia, a difference that was not statistically significant ^[3]. When the two arms were pooled, the risk of probable dementia was about 76% higher on hormones ^[3]. The researchers concluded that hormone therapy should not be used to prevent dementia or cognitive decline in women 65 and older ^[3].

The Menopause Society adds that the effect of hormone therapy may depend on cognitive function at the start, with more favorable effects in women whose cognition was normal before they began ^[1].

What about women closer to menopause?

WHIMS tells us about starting hormones at 65 or older. FDA labeling notes it is unknown whether the WHIMS findings apply to younger postmenopausal women ^[10]. Three trials looked at younger women, and The Menopause Society describes their results as neutral for cognitive function ^[1].

• WHIMS-Y: 1,326 women who had started hormones at ages 50 to 55 were tested about 7 years after the trials ended, at an average age of 67 ^[4]. Their thinking scores were similar to those of women who had taken placebo ^[4].
• KEEPS-Cog: 693 women, average age 52.6 and about 1.4 years past their last period, took oral estrogen, a transdermal estradiol patch, or placebo for up to 4 years ^[5]. Neither hormone regimen improved cognition ^[5]. Mood symptoms improved somewhat with oral estrogen, but not with the patch ^[5].
• ELITE-Cog: 567 women took oral estradiol or placebo for an average of 57 months ^[6]. Estradiol neither helped nor harmed verbal memory, executive function, or overall cognition, whether it was started within 6 years of menopause or 10 or more years after ^[6].

These trials measured memory and thinking test scores over a few years, not dementia diagnoses. The KEEPS authors note their results cannot be extended to treatment longer than 4 years ^[5]. So they are reassuring about short-term cognition, but they cannot tell us whether starting early changes dementia risk decades later.

What large observational studies show

Without long trials, researchers have turned to national health records. Their results point in different directions.

• Finland, 2019: Comparing 84,739 women with Alzheimer disease with the same number of matched women without it, systemic hormone therapy was linked to a 9% to 17% higher risk of Alzheimer disease ^[7]. Vaginal estradiol used on its own was not linked to higher risk ^[7].
• UK, 2021: Among 118,501 women with dementia and 497,416 matched women without it, hormone therapy overall was not linked to higher dementia risk ^[8]. Using estrogen plus progestogen for 5 years or more was linked to a slightly higher risk of Alzheimer disease specifically, about 5 to 7 extra cases per 10,000 women per year ^[8].
• Denmark, 2023: In women who were 50 to 60 years old in 2000, estrogen plus progestogen was linked to a higher rate of dementia, including in women who started at 55 or younger, and with both continuous and cyclic schedules ^[9].

Why the disagreement? Observational studies compare women who chose hormones with women who did not, and those groups can differ in ways researchers cannot fully measure. The Danish authors said more research is needed to tell whether their findings reflect a real effect of hormone therapy or an underlying predisposition in the women who needed these treatments ^[9].

One more piece of the puzzle: The Menopause Society notes that 18-year WHI follow-up showed lower Alzheimer disease mortality in women randomized to hormones, significant for estrogen alone and driven by women who were in their 70s when they enrolled ^[1]. Results like these keep the question open rather than settled.

What about brain fog right now?

Brain fog is worth raising with a clinician. On the specific question of whether hormones sharpen thinking, The Menopause Society classes the effect of hormone therapy in early natural postmenopause as neutral in trials ^[1]. It notes one exception: estrogen may have cognitive benefits when started immediately after surgery that removes the uterus and both ovaries ^[1].

If hot flashes and night sweats are breaking up your sleep, treating those symptoms is a reasonable goal on its own, and hormone therapy is the most effective treatment for them ^[1]. Just go in with the right expectations: the goal is symptom relief, not dementia prevention.

Who should think hardest about this

The Menopause Society says women who start hormone therapy after 60, or more than 10 years after menopause, face a less favorable benefit-risk balance, partly because of greater absolute risks of dementia, as well as heart disease, stroke, and blood clots ^[1]. Initiating hormone therapy after 65 increased dementia risk in the WHIMS trial ^[1].

If you are in that group and considering hormones, it is worth a careful conversation about why, for how long, and at what dose. For the wider picture, read is HRT safe? and HRT and heart disease.

Talking it through with WarriorBabe Health

A WarriorBabe Health clinician reviews your age, time since menopause, and health history before deciding whether hormone therapy fits your symptoms. Options include oral estradiol, an estradiol patch, estradiol cream, and a progesterone capsule for women with a uterus. Compare them on our hormone treatments page.

Our hormone products are compounded by a licensed pharmacy. Compounded drugs are not FDA-approved, which means the FDA does not review their safety, effectiveness, or quality before they are marketed ^[11]. None of our treatments is offered to prevent dementia.

Curious whether hormone therapy could help your symptoms? Take the 2-minute quiz. A licensed clinician makes the final call on whether any prescription is appropriate.

This article is for general information. It is not medical advice and does not replace a visit with a licensed clinician who knows your history. Do not start, stop or change a medication without talking to your clinician. If you think you are having a medical emergency, call 911.